AGIOS PHARMACEUTICALS, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 19.73 million shares for the 1-month period ending 2013-07-29, per its 10-Q filed 2013-11-07.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2014-11-07
- 2013-07-29: Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month 19.73M shares; Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month 19.73M shares.
- 2013-06-30: Stock Issued During Period, Shares, Conversion of Convertible Securities 6 month 19.73M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month | Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month | Stock Issued During Period, Shares, Conversion of Convertible Securities 6 month |
|---|---|---|---|
| 2013-07-29 | 19.73M shares 10-Q · filed 2014-11-07 | 19.73M shares 10-Q · filed 2013-11-07 | |
| 2013-06-30 | 19.73M shares 10-Q · filed 2013-09-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |